Inhibitory effect of Trolox on the migration and invasion of human lung and cervical cancer cells

International Journal of Molecular Medicine

Volumn 29, Issue 2, 2012, Pages 245-251

  Sung, Ho Joong ^a   Kim, Yoonseo ^b   Kang, Hyereen ^b   Sull, Jae Woong ^a   Kim, Yoon Suk ^c   Jang, Sung Wuk ^b   Ko, Jesang ^b  

^a Eulji University   (South Korea)

^b Korea University   (South Korea)

^c Yonsei University Wonju   (South Korea)

Author keywords

Cell migration; Cervical cancer; Invasion; Lung cancer; Matrix metalloproteinase 9; Trolox

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TROLOX C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHROMANS; FEMALE; HELA CELLS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

EID: 84855162170     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.832     Document Type: Article

References (31)

1. Mareel M and Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376, 2003. (Pubitemid 36382891)
2. Johnsen M, Lund LR, Romer J, Almholt K and Dano K: Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998. (Pubitemid 28477027)
3. Curran S and Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36: 1621-1630, 2000. (Pubitemid 30616366)
4. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000. (Pubitemid 30123793)
5. Itoh Y and Nagase H: Matrix metalloproteinases in cancer. Essays Biochem 38: 21-36, 2002. (Pubitemid 36589192)
6. Orlichenko LS and Radisky DC: Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 25: 593-600, 2008.
7. Park JH, Jeong YJ, Park KK, et al: Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells 29: 209-215, 2010.
8. Tang CH, Tan TW, Fu WM and Yang RS: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29: 35-43, 2008. (Pubitemid 351201739)
9. Yu W, Liu J, Xiong X, Ai Y and Wang H: Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract 205: 709-715, 2009.
10. Takahashi C, Sheng Z, Horan TP, et al: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221-13226, 1998. (Pubitemid 28509552)
11. Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49: 1603-1616, 2010.
12. Wu WS: The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25: 695-705, 2006.
13. Sotgia F, Martinez-Outschoorn UE and Lisanti MP: Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 9: 62, 2011.
14. Yang J, Wei D and Liu J: Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate. Biomed Pharmacother 59: 98-103, 2005. (Pubitemid 40424556)
15. Woo JH, Lim JH, Kim YH, et al: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853, 2004. (Pubitemid 38445410)
16. Lúcio M, Nunes C, Gaspar D, Ferreira H, Lima JLFC and Reis S: Antioxidant activity of vitamin E and Trolox: understanding of the factors that govern lipid peroxidation studies in vitro. Food Biophysics 4: 312-320, 2009.
17. 14C tracer and product studies. Biochim Biophys Acta 1237: 77-85, 1995.
18. Forrest VJ, Kang YH, McClain DE, Robinson DH and Ramakrishnan N: Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med 16: 675-684, 1994. (Pubitemid 24193514)
19. Haug C, Lenz C, Diaz F and Bachem MG: Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 1823-1829, 2004. (Pubitemid 39350298)
20. Nelson KK, Subbaram S, Connor KM, et al: Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J Biol Chem 281: 14100-14110, 2006. (Pubitemid 43848337)
21. Sheu BC, Lien HC, Ho HN, et al: Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63: 6537-6542, 2003.
22. Chu SC, Chiou HL, Chen PN, Yang SF and Hsieh YS: Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol Carcinog 40: 143-149, 2004.
23. Sung HJ, Ma W, Wang PY, et al: Mitochondrial respiration protects against oxygen-associated DNA damage. Nat Commun 1: 5, 2010.
24. Zhang Z, Oliver P, Lancaster JR Jr, et al: Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J 15: 303-305, 2001.
25. Nomura N, Nomura M, Sugiyama K and Hamada J: Phorbol 12-myristate 13-acetate (PMA)-induced migration of glioblastoma cells is mediated via p38MAPK/Hsp27 pathway. Biochem Pharmacol 74: 690-701, 2007. (Pubitemid 47087761)
26. Park SK, Hwang YS, Park KK, Park HJ, Seo JY and Chung WY: Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 30: 1225-1233, 2009.
27. Roomi MW, Monterrey JC, Kalinovsky T, Rath M and Niedzwiecki A: Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncol Rep 21: 1323-1333, 2009.
28. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002. (Pubitemid 34270240)
29. Klein EA, Thompson IM, Lippman SM, et al: SELECT: the next prostate cancer prevention trial. Selenum and vitamin E cancer prevention trial. J Urol 166: 1311-1315, 2001. (Pubitemid 32862164)
30. Maggi-Capeyron MF, Ceballos P, Cristol JP, et al: Wine phenolic antioxidants inhibit AP-1 transcriptional activity. J Agric Food Chem 49: 5646-5652, 2001. (Pubitemid 33089720)
31. van den Berg R, Haenen GR, van den Berg H and Bast A: Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr 86 (Suppl 1): S121-S127, 2001. (Pubitemid 32916187)